Vertical Designs Ltd. Signs LOI With Cromogen Biotechnology
VANCOUVER, Nov. 8, 2012 /CNW/ - Vertical Designs Ltd. of Vancouver, B.C. is moving rapidly into the biotech, pharmaceutical, and nutraceutical arenas. The company has recently signed a letter of intent with Cromogen Biotechnology, a licensed research and development firm with offices in Central and South America. The union will spark cooperative research toward the augmentation of phytocannabinoids, (also called "natural cannabinoids") through environmental changes and breeding.
Cromogen CEO, Michael Brubeck reports,"Cromogen sees great opportunity in accelerating research into cannabis plant physiology with Vertical Designs. With Stage 3 clinical trials beginning in Q2 2013, this will give our company greater efficiency in manufacturing isolated non-psychoactive molecules for use in our combination drug therapy, targeted for chemotherapy-induced nausea."
"Cromogen offers a wealth of experience in greenhouse-based technology. As this team merges into the vertical farming arena, we see tremendous potential for even further advancement," says Vertical Designs CEO, Nick Brusatore. "This progressive alliance will serve our vision to revolutionize agricultural and pharmaceutical practices on a global level."
Vertical Designs has plans to spin off a wholly owned subsidiary company that will hold exclusive master licensing and rights of advanced designs in the biotech, pharmaceutical, and nutraceutical arenas. The firm will be seeking a capital partner in the near future.
About Vertical Designs Ltd.
Vertical Designs Ltd. designs and manufactures cutting-edge vertical farming technology. The company is helmed by Nick Brusatore - an innovative eco-entrepreneur, natural capitalist, mechanical designer, and inventor.
About Cromogen Biotech.
Cromogen is a research and development firm for cannabinoid-class molecules in Latin America, with approvals for clinical trials from the Department of Health in multiple countries. With a portfolio of proprietary administration methods and unparalleled quality control systems, Cromogen is defining the market for cannabinoid-class pharmaceuticals and is poised to become the region's sole cannabinoid pharmaceutical company.
SOURCE: Vertical Designs Ltd.For further information: